JP2014524241A5 - - Google Patents

Download PDF

Info

Publication number
JP2014524241A5
JP2014524241A5 JP2014524112A JP2014524112A JP2014524241A5 JP 2014524241 A5 JP2014524241 A5 JP 2014524241A5 JP 2014524112 A JP2014524112 A JP 2014524112A JP 2014524112 A JP2014524112 A JP 2014524112A JP 2014524241 A5 JP2014524241 A5 JP 2014524241A5
Authority
JP
Japan
Prior art keywords
collagen
functional fragment
nucleic acid
cell
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014524112A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014524241A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/049553 external-priority patent/WO2013020064A1/en
Publication of JP2014524241A publication Critical patent/JP2014524241A/ja
Publication of JP2014524241A5 publication Critical patent/JP2014524241A5/ja
Pending legal-status Critical Current

Links

JP2014524112A 2011-08-03 2012-08-03 コラーゲン7及び関連する方法 Pending JP2014524241A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161514796P 2011-08-03 2011-08-03
US61/514,796 2011-08-03
PCT/US2012/049553 WO2013020064A1 (en) 2011-08-03 2012-08-03 Collagen 7 and related methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017171852A Division JP2017209117A (ja) 2011-08-03 2017-09-07 コラーゲン7及び関連する方法

Publications (2)

Publication Number Publication Date
JP2014524241A JP2014524241A (ja) 2014-09-22
JP2014524241A5 true JP2014524241A5 (enExample) 2015-07-23

Family

ID=47629706

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014524112A Pending JP2014524241A (ja) 2011-08-03 2012-08-03 コラーゲン7及び関連する方法
JP2017171852A Abandoned JP2017209117A (ja) 2011-08-03 2017-09-07 コラーゲン7及び関連する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017171852A Abandoned JP2017209117A (ja) 2011-08-03 2017-09-07 コラーゲン7及び関連する方法

Country Status (10)

Country Link
US (1) US9676837B2 (enExample)
EP (1) EP2753704A4 (enExample)
JP (2) JP2014524241A (enExample)
KR (1) KR20140054160A (enExample)
CN (2) CN108165593A (enExample)
AU (2) AU2012289916B2 (enExample)
BR (1) BR112014002546A2 (enExample)
CA (1) CA2843896A1 (enExample)
MX (1) MX351565B (enExample)
WO (1) WO2013020064A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2328446T5 (es) 2000-02-04 2014-02-27 Children's Hospital Research Foundation Uso de lipasa ácida lisosomal para tratar la aterosclerosis y enfermedades asociadas
MX338426B (es) 2010-04-23 2016-04-15 Synageva Biopharma Corp Enzima de enfermedad del almacenamiento lisosomico.
DK2613798T4 (en) 2010-09-09 2018-04-16 Synageva Biopharma Corp USING LYSOSOMAL SUR LIPASE TO TREAT PATIENTS WITHOUT LYSOSOMAL SUR LIPASE
EP2675472A4 (en) 2011-02-15 2014-09-17 Synageva Biopharma Corp METHOD FOR THE TREATMENT OF LACK OF LYSOSOMAL SAURER LIPASE
US9040484B2 (en) * 2011-04-26 2015-05-26 The Board Of Trustees Of The Leland Stanford Junior University Production and delivery of a stable collagen
CN105940110A (zh) 2014-01-31 2016-09-14 菲克特生物科学股份有限公司 用于核酸产生和递送的方法和产品
US10227394B2 (en) 2014-04-08 2019-03-12 University Of Southern California Polypeptide compositions with type VII collagen fibronectin type III-like repeats and treatment methods for wound closure and healing
KR102204367B1 (ko) * 2014-07-16 2021-01-19 주식회사 엘지생활건강 피부 주름 개선용 화장료 조성물
WO2016131052A1 (en) 2015-02-13 2016-08-18 Factor Bioscience Inc. Nucleic acid products and methods of administration thereof
GB201601571D0 (en) * 2016-01-28 2016-03-16 Nordic Bioscience As Collagen type Vll alpha 1 assay
WO2017160636A1 (en) * 2016-03-16 2017-09-21 Shire Human Genetic Therapies, Inc. Methods of purifying collagen 7
IL308824A (en) 2016-08-17 2024-01-01 Factor Bioscience Inc Nucleic acid products and methods of administration thereof
US11028146B2 (en) * 2017-09-22 2021-06-08 Modern Meadow, Inc. Recombinant yeast strains
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
CN109022464A (zh) * 2018-07-02 2018-12-18 西安巨子生物基因技术股份有限公司 重组人源型胶原蛋白的羟基化方法
TWI818166B (zh) * 2019-03-27 2023-10-11 美商菲尼克斯組織修復公司 用於生產膠原蛋白7組合物之系統及方法
TW202104254A (zh) 2019-04-12 2021-02-01 美商格爾托公司 重組彈性蛋白及其生產
JP7699552B2 (ja) 2019-07-03 2025-06-27 ファクター バイオサイエンス インコーポレイテッド カチオン性脂質及びその使用
US10501404B1 (en) 2019-07-30 2019-12-10 Factor Bioscience Inc. Cationic lipids and transfection methods
AU2021211721A1 (en) 2020-01-24 2022-08-18 Geltor, Inc. Animal-free dietary collagen
KR20240004264A (ko) * 2021-03-04 2024-01-11 젤라텍, 인크. 배양된 동물 세포로부터의 콜라겐을 사용한 재료의 제조 방법
US20240424065A1 (en) 2021-10-12 2024-12-26 Phoenix Tissue Repair, Inc. Collagen 7 protein replacement therapy
CN117143223B (zh) * 2022-08-23 2024-03-08 山西锦波生物医药股份有限公司 一种生物合成人体结构性材料的制备方法
CN116854807A (zh) * 2023-07-26 2023-10-10 浙江大学 一种重组人源ⅶ型胶原蛋白及其制备方法与应用
CN120137008B (zh) * 2025-03-18 2025-09-26 广东普言生物科技有限公司 一种重组Ⅶ型胶原蛋白Pro.C7及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020142391A1 (en) 1991-06-12 2002-10-03 Kivirikko Kari I. Synthesis of human procollagens and collagens in recombinant DNA systems
AU6181300A (en) * 1999-07-29 2001-02-19 Helix Research Institute Liver cancer-associated genes
US7026463B2 (en) * 1999-08-13 2006-04-11 Matthew Glenn Polynucleotides and polypeptides, materials incorporating them and methods for using them
HK1046004B (en) 1999-11-12 2013-11-08 Fibrogen, Inc. Recombinant gelatins
CN1552889A (zh) * 2003-12-18 2004-12-08 四川铭让生物科技有限公司 制备胶原蛋白和胶原多肽的方法及其用途
JP4490498B2 (ja) 2008-09-30 2010-06-23 新田ゼラチン株式会社 疾病抑制剤
US9040484B2 (en) 2011-04-26 2015-05-26 The Board Of Trustees Of The Leland Stanford Junior University Production and delivery of a stable collagen

Similar Documents

Publication Publication Date Title
JP2016105737A5 (enExample)
AR124871A2 (es) Métodos de fabricación para el control del contenido de lisina c-terminal, galactosa y ácido siálico en proteínas recombinantes
JP2015521848A5 (enExample)
MX345729B (es) Proteina activadora del ensamblaje (aap) y su uso para la fabricacion de particulas de parvovirus que consisten esencialmente de vp3.
JP2022552183A5 (enExample)
MX2011011215A (es) Polipeptido que degrada carbohidratos y usos del mismo.
HRP20190970T1 (hr) Polipeptidi koji sadrže neglikozilirani fc
JP2014524241A (ja) コラーゲン7及び関連する方法
WO2016092550A3 (en) Methods of producing long acting ctp-modified polypeptides
FI3536797T3 (fi) Siirtogeenin tehostettu ilmentäminen ja prosessointi
JP2005120106A5 (enExample)
CN103122027A (zh) 一种重组人源胶原蛋白及其生产方法
AR080942A1 (es) Produccion de proteinas heteromultimericas
MY176331A (en) Carbohydrate degrading polypeptide and uses thereof
DE602008002593D1 (de) Verfahren zur herstellung eines rekombinanten polyklonalen proteins
MX2012005864A (es) Proteinas de enlace al antígeno anti-orai 1 y usos de las mismas.
RU2010108308A (ru) Способ получения гетерогенных белков
WO2008114673A1 (ja) ポリペプチドの製造方法
NZ742660A (en) Variants of chymosin with improved milk-clotting properties
WO2013163654A3 (en) Nucleic acids, cells, and methods for producing secreted proteins
NZ589806A (en) Variant hedgehog-interacting protein (hhip1) and methods and uses thereof
JP2017524366A5 (enExample)
US10294284B2 (en) Method for preparing C1q recombinant protein
CN105154461A (zh) 一种利用骨架蛋白Fn3在大肠杆菌体内建立N-糖基化效率检测受体蛋白模型的方法
CN105296506A (zh) 以硫磺菌蘑菇凝集素n-乙酰氨基乳糖胺结合域作为融合标签的目标蛋白表达与纯化方法